Sanofi Sues Amgen To Protect Eczema Drug From IP Claims
Sanofi SA and partner Regeneron Pharmaceuticals sued Amgen Inc. in Massachusetts federal court Monday, seeking a court order declaring that its eczema drug Dupixent doesn't infringe an Amgen Inc. patent for...To view the full article, register now.
Already a subscriber? Click here to view full article